203
Views
0
CrossRef citations to date
0
Altmetric
REVIEW

Subcutaneously-Administered Infliximab in the Management of Rheumatoid Arthritis: A Short Narrative Review of Current Clinical Evidence

ORCID Icon, , , ORCID Icon &
Pages 3259-3267 | Published online: 01 Jun 2022

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

For more information please visit our Permissions help page.